The activity-based office : The cellular office challenger?

Introduction: The activity-based office has had a breakthrough in the past few years. One of the reasons for this is that the technology now allows it to work properly. The concept is a type of open landscaped office that put its main focus on the design of the physical work environment. The office is divided in different areas with the purpose to match employees’ different tasks. There is still not much research done on the new concept and the research that has been carried out has been carried out in connection with the move or a maximum of 15 months after the move to the new office. Purpose: The study aimed at comparing employees' perceived perception of the classic office and the activity-based office abilities with regard to leadership, health, productivity and the social work environment. The essay also concerns how well designed the activity-based office layout is. Method: The study was a quantitative survey and the data was collected through a web survey. The web survey consisted of 25 questions relating to the categories of social, leadership, health, productivity and office layout. Analysis: The data was analyzed by generation of mean values for each category, broken down by gender, age, time in activity-based office and the total from every respondent. The data was also analyzed by a correlation analysis. Results: According to the results that was collected, the activity-based office had a overbalanced positive experience than the classical office in each category investigated, except the category regarding health. Conclusions: Based on the results, it can be noted that an activity-based office towards a classic office provides a higher value for employees in social, leadership, productivity and design. In health, however, it gives a lower value, which shows that employees had better health in the classical office. The results show that the survey can confirm what previous research has said. However, the result can not be generalized on an entire population as the number of respondents and variations was too small. To be able to generalize the results further research must be done.Introduktion: Aktivitetsbaserade kontor är något som de senaste åren blivit mer och mer vanligt. Till följd av informationsteknikens framfart har denna kontorsutformning tillåtits att fungera på ett effektivt sätt. Konceptet är en typ av öppet kontorslandskap där medarbetaren saknar en fast plats. Mycket vikt läggs på den fysiska utformningen, där olika zoner delar in kontoren i aktiva, stillsamma och tysta områden. Tidigare forskning kring det nya konceptet är otillräcklig då den forskning som finns är genomförd i samband med flytten eller max 15 månader efter inflyttningen. Syfte: Studien syftade till att jämföra medarbetares upplevda uppfattning av cellkontorets och det aktivitetsbaserade kontorets förmågor med avseende på ledarskap, hälsa, produktivitet, den sociala arbetsmiljön. Uppsatsen berör även hur väl utformat det aktivitetsbaserade kontoret är. Metod: Studien var en kvantitativ undersökning och datan som används samlades in genom en webbenkät. Enkäten bestod av 25 frågor som berörde kategorierna socialt, ledarskap, hälsa, produktivitet och kontorets utformning. Analys: Datan analyserades genom framtagande av medelvärden för respektive kategori. Totalt, uppdelat efter kön, ålder samt tid i aktivitetsbaserat kontor. Datan analyserades även genom en korrelationsanalys. Resultat: Från resultatet går det att utläsa att det aktivitetsbaserade kontoret upplevdes bättre än det klassiska cellkontoret i varje kategori förutom kategorin angående hälsa. Slutsats: Utifrån resultaten går det att konstatera att ett aktivitetsbaserat kontor gentemot ett cellkontor ger ett högre värde för de anställda i det sociala, ledarskap, produktivitet och utformning. I hälsa ger den dock sämre ett sämre värde. Resultatet visar att undersökningen kan konstatera vad tidigare forskning har bekräftat. Dock går inte resultatet att generalisera på en hel population då antal respondenter och variation var för liten. Detta är något som måste göras i ytterligare forskning

Principes fondamentaux de droit applicables à la santé

SYL-001146 = Fascicule 2 ;SYL-001147 = Documentation accompagnant le fascicule 2Fascicule 2 :Droit à la santé et législation sanitaire -- Documentation accompagnant le fascicule 2 :Droit de la santé et législation sanitaire1re licence en sciences de la santé publique (Licence en gestion des institutions de soins), Diplôme d'études spécialisées en sciences de la santé (maîtrise en santé publique), Diplôme d'études spécialisées de Médecin Hygiéniste, Diplôme d'études spécialisées en médecine du travailinfo:eu-repo/semantics/published

Principes fondamentaux de droit applicables à la santé

SYL-002090 = Fascicule 2 ;SYL-002097 = Documentation accompagnant le fascicule 2Fascicule 2 :Droit de la santé et législation sanitaire1re Licence en Sciences de la Santé Publique (Licence en Gestion des Institutions de Soins), Diplôme d'études spécialisées en Sciences de la Santé (Maitrise en Santé Publique), Diplôme d'études spécialisées de Médecin Hygiéniste, Diplôme d'études spécialisées en Médecine du travail - GEST 076info:eu-repo/semantics/published

Principes fondamentaux de droit applicables à la santé

SYL-6404 = Documentation accompagnant le fascicule 2: Droit de la santé et législation sanitaire ;SYL-6459 = Fascicule 2Fascicule 2 :Droit de la santé et législation sanitaire1re licence en sciences de la santé publique ( Licence en gestion des institutions de soins), Diplôme d'études spécialisées en Sciences de la santé (Maitrise en santé publique); Diplôme d'études spécialisées en Médecin Hygiéniste, Diplôme d'études spécialisées en Médecine du travail - GEST 076info:eu-repo/semantics/published

Inhibitory Effect of a Highly Potent Antagonist of LH Releasing Hormone (SB-75) on the Pituitary Gonadal Axis in the Intact and Castrated Rat

The biological potency of the new, highly potent antagonist [AC-D-Nal (2)1, E-Phe(4Cl)2, D-Pal(3)3, E > -Cit6, D-Ala10] LH-RH (SB-75) on the pituitary-gonadal system of female castrated and intact ovulating rats was tested. Administration of a single dose (50-100 µg/kg BW) of the antagonist SB-75 inhibited effectively the elevated gonadotrophin levels for 48 h. Pituitary LH and FSH content was not affected by SB-75 treatment. When administered in the early afternoon of the proestrus to intact cycling rats, SB-75 blocked the preovulatory LH surge as well as the primary and secondary FSH surges. However, the secondary FSH surge was not affected by SB-75 treatment when administered on the evening of proestrus suggesting its independence from the LH-RH mechanism. A group of ovariectomized rats was chronically treated with D-Trp6-LH-RH after having been pretreated by administration of a single dose of the antagonist. The initial stimulatory release of LH and FSH initiated by injection of the LH-RH agonist was significantly reduced by pretreatment with the LH-RH antagonist. We conclude that the LH-RH antagonist SB-75 may be used effectively in the field of reproductive dysfunction and endocrinological oncology and may become an invaluable physiological probe in studying the hormonal dynamics of the reproductive endocrine axis

Induction of ovulation with D-Trp6-LHRH combined with purified FSH in patients with polycystic ovarian disease

Seventeen patients with polycystic ovarian disease (PCOD) and evidence of mild or severe ovarian hyperstimulation syndrome (OHSS) during therapy with CC/hCG, FSH/hCG or hMG/hCG were treated with D-Trp6-LHRH until medical gonadectomy was attained. Under the suppressive therapy with the GnRH agonist (GnRHa) ovulation was induced with FSH/hCG. In 15 out of 17 patients, ovulatory cycles were obtained with this new modality of treatment. Seven patients conceived (3 viable pregnancies and 4 early abortions) after the 1st treatment cycle. Fourteen of the 17 patients demonstrated symptoms of mild OHSS which did not require hospitalization. Only 1 patient developed severe OHSS after the combined treatment. Our results suggest that therapy with GnRHa, especially in its delayed release formulation, is effective for the prevention of severe ovarian hyperstimulation in PCOD patients undergoing treatment with menotropins for the induction of ovulation